CAIDYA
LIVE

Serial Number

97533889

Owner

Clinipace, Inc.

Attorney

Margarita Wallach, Esq.

Filing Date

Aug 3, 2022

Add to watchlist:

No watchlists yet
View on USPTO

CAIDYA Trademark

Serial Number: 97533889

CAIDYA is a trademark filed by Clinipace, Inc. on August 3, 2022. The trademark is classified under Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 37 (Building & Construction), Class 38 (Telecommunications), Class 39 (Transportation & Storage), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Clinipace, Inc. (14 trademarks)

Suite 100
Morrisville, NC 27560

Entity Type: 03

Trademark Details

Filing Date

August 3, 2022

Registration Date

Not Registered

Published for Opposition

January 23, 2024

Goods & Services

Consultation in the field of publishing and issuing scientific papers in relation to conducting clinical trials, regulatory affairs, drug development, manufacturing compliance and validation, advanced technology, clinical benchmarking and clinical performance improvement in the field of international health and in the pharmaceutical, biotechnology, and medical device industries

Computer software, namely, downloadable computer programs and downloadable computer programs provided via a website for accessing, collecting, managing, tracking, analyzing, and reporting data and information on clinical trials, computer program systems consisting of computer hardware and recorded software systems for accessing, collecting, managing, tracking, analyzing, and reporting data and information on clinical trials and program libraries in the nature of electronic databases recorded on a data carrier in the field of pharmaceutical research and development and printed and electronic users manuals for use therewith sold as a unit

Clinical trial logistical services, namely, delivering clinical trial kits to sites, delivering wearable devices to patients and/or site locations

Providing user access to a global computer network in connection with clinical trials and drug development; Provision of access to a computer network in connection with clinical trials and drug development

Real estate site selection namely, building inspecting in the course of building construction of potential sites for hosting clinical trials

Medical and pharmaceutical consultation

Study equipment for clinical trials, namely, patient monitors and patient sensors for monitoring and measuring blood properties and respiratory events, medical instruments to measure blood pressure, cardiac output and other physiological and cardiovascular parameters, medical imaging devices for the brain, and similar medical apparatus for detecting symptoms related to specific disease types in the fields of cardiology, cell and genes, gastroenterology, infectious diseases, nephrology, neurology, oncology, rare diseases, respiratory, and women's health, for use in clinical trials

Inspecting potential sites for hosting clinical trials for quality control purposes; providing temporary use of web-based computer software programs for accessing, collecting, managing, tracking, analyzing, and reporting data and information on clinical trials

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 19, 2025 EXRA
SOU EXTENSION 3 GRANTED
Sep 18, 2025 EX3G
SOU EXTENSION 3 FILED
Sep 18, 2025 EXT3
SOU TEAS EXTENSION RECEIVED
Sep 18, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 20, 2025 EXRA
SOU EXTENSION 2 GRANTED
Mar 19, 2025 EX2G
SOU EXTENSION 2 FILED
Mar 19, 2025 EXT2
SOU TEAS EXTENSION RECEIVED
Mar 19, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 17, 2024 EXRA
SOU EXTENSION 1 GRANTED
Sep 17, 2024 EX1G
SOU EXTENSION 1 FILED
Sep 17, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Sep 17, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 19, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 23, 2024 NPUB
PUBLISHED FOR OPPOSITION
Jan 23, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 3, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 16, 2023 CNSA
EXAMINER'S AMENDMENT ENTERED
Dec 16, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Dec 16, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Dec 16, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Dec 16, 2023 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 2, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 1, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 1, 2023 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Sep 5, 2023 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Sep 5, 2023 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 2, 2023 GNRN
NON-FINAL ACTION E-MAILED
Jun 2, 2023 GNRT
NON-FINAL ACTION WRITTEN
Jun 2, 2023 CNRT
ASSIGNED TO EXAMINER
May 19, 2023 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Aug 26, 2022 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 25, 2022 NWOS
NEW APPLICATION ENTERED
Aug 6, 2022 NWAP